TrialInternational journal of stroke : official journal of the International Stroke Society2015

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388).

TARDIS Trial Investigators et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.